Aptus Pharma IPO
Open SmeCurrent GMP
₹4 (+5.71%)
Price Band
₹ 65 – 70
Lot Size
200
Issue Size
₹13.02 Cr
Minimum Investment
₹28000 (400 Shares)
Listing Date
30 September 2025
Subscription
22.4x
About the Company
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
- Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.
- Aptus CD care: Focused on chronic therapies
- Aptus Wellcare: Offers wellness and nutraceutical products
- Aptus Global: Export in overseas market
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Promoters
- Tejash Maheshchandra Hathi
- Chatrabhuj Vallabhbhai Butani
- Kapilbhai Hasmukhbhai Chandarana
- Ghanshyam Vinubhai Pansuriya
- Milly Chetan Lalseta
- Riddhish Natwarlal Tanna
- Gaurang Rameshchandra Thakker
- Kripaliben Mayank Thakker
- Kunjal Piyushbhai Unadkat
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
72.89%
Objects of the Issue
The Company Aptus Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure for Office Premises with furniture and Industrial Racks
- Working Capital
- General corporate purposes
Address / Contact Info
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok - 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: info@aptuspharma.com
Website: https://aptus-pharma.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Tuesday, 23 September 2025
IPO Close Date
Thursday, 25 September 2025
Basis of Allotment
Friday, 26 September 2025
Initiation of Refunds
Monday, 29 September 2025
Credit of Shares to Demat
Monday, 29 September 2025
Listing Date
Tuesday, 30 September 2025 — NSE & BSE
Important Dates
Open Date
23 September 2025
Close Date
25 September 2025
Basis Of Allotment
26 September 2025
Listing Date
30 September 2025
Financial Performance (₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 21.92 | 10.03 | 6.22 |
| Revenue | 24.64 | 17.88 | 13.9 |
| Profit After Tax | 3.1 | 0.8 | 0.19 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Reserve & Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowings | 10.36 | 5.31 | 2.21 |
EPS Pre
6.20%
EPS Post
4.52%
P/E Pre
11.29
P/E (Post Issue)
15.49x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 44.5 | 45.18 | 20.06 |
| ROCE % | 45.66 | 21.7 | 12.77 |
| Debt / Equity | 1.49 | 3 | 2.28 |
| RoNW % | 44.5 | 45.18 | 20.06 |
| PbW | 0 | 0 | 0 |
| Pat Margin % | 0 | 0 | 0 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 352000 | 28.43 | 0 |
| Non-Institutional | 266000 | 21.49 | 0 |
| BNII | 178000 | 14.38 | 0 |
| SNII | 88000 | 7.11 | 0 |
| Retail Investors | 620000 | 50.08 | 0 |
| Total | 1238000 | 100 | 0 |
Subscription Status ( Thu, 25 Sep 25 01:31 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 352000 | 436000 | 1.24x |
| Non-Institutional | 266000 | 7742000 | 29.11x |
| Retail Investors | 620000 | 19552000 | 31.54x |
| Total | 1238000 | 27730000 | 22.4x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Aptus Pharma Limited | 10 | 0.00 | 5.32 | 5.32 | 44.50 | 13.93 |
| Zota health care limited | 10 | 382.12 | 3.16 | 3.16 | 2.72 | 110.83 |
| Sunrest Lifescience Ltd | 10 | 10.56 | 4.66 | 4.66 | 12.36 | 37.72 |
| Lincoln Pharmaceuticals Ltd | 10 | 13.53 | 41.11 | 41.11 | 12.26 | 335.34 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | 280,000.00 |
| Retail (Max) | 2 | 4,000 | 280,000.00 |
| S-HNI (Min) | 3 | 6,000 | 420,000.00 |
| S-HNI (Max) | 7 | 14,000 | 980,000.00 |
| B-HNI (Min) | 8 | 16,000 | 1,120,000.00 |
Registrar
Bigshare Services Pvt Ltd
91-22-6263 8200
investor@bigshareonline.com
https://www.bigshareonline.com
Book Running Lead Managers
- Interactive Financial Services Ltd
RHP Document
DRHP Document
Anchor Investors
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Aptus Pharma IPO is a Book-building IPO worth ₹13.02 crores. The price band is ₹65 to 70 per share. The IPO opens on Tue, Sep 23, 2025 and closes on Thu, Sep 25, 2025. It will be listed on BSE and NSE. Bigshare Services Pvt Ltd is the registrar.
The Aptus Pharma IPO opens on Tue, Sep 23, 2025 and closes on Thu, Sep 25, 2025
Aptus Pharma IPO Price Band is ₹65 to 70.
Aptus Pharma IPO lot size is 200, and the minimum amount required for application is ₹28000.
The minimum investment for Aptus Pharma IPO is approximately ₹28000 based on the upper price band.
To apply for the Aptus Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Thu, Sep 25, 2025. After submission, funds are blocked until the basis of allotment of Aptus Pharma IPO is finalised.
Aptus Pharma IPO issue size is ₹13.02 crores.
Aptus Pharma IPO allotment date is Sat, Jun 27, 2026.
The registrar for Aptus Pharma IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Aptus Pharma IPO through their official website or helpline.
The Aptus Pharma IPO GMP (Grey Market Premium) is ₹4 as of Tue, Sep 30, 2025. Based on the upper price band of ₹70 per share, the estimated Aptus Pharma IPO listing price is ₹74, indicating a potential listing gain of approximately 31% over the issue price.